Lymphoma is not one disease. Treatment depends on the exact lymphoma subtype, pathology, molecular findings, disease extent, symptoms, previous therapy and patient fitness. Confirmation of the diagnosis can therefore be especially important before an international treatment plan is made.
Pathology and subtype matter
A German hematology center may ask to review pathology or request additional testing because treatment pathways differ substantially between lymphoma subtypes. International patients should be prepared to provide the original pathology report and information about where tissue material is stored.
Records for a lymphoma consultation
A complete package should document both the diagnosis and the treatment history.
- Pathology / histology and immunophenotyping results
- Molecular or cytogenetic findings when available
- PET/CT, CT or other staging imaging
- Bone-marrow results when performed
- Previous chemotherapy, antibody, targeted or cellular therapy
- Current blood counts and major laboratory results
- Current symptoms and treatment response
Second opinion and advanced therapies
University hematology centers may assess whether additional pathology review, another systemic strategy, transplant or cellular therapy should be considered. Eligibility for any advanced treatment is individualized and cannot be assumed from a diagnosis name alone.
How to evaluate a German cancer center
Use verifiable quality signals rather than paid ranking labels. Disease-specific certification, multidisciplinary review, transparent official contact routes and continuity-of-care planning are more useful than a generic claim that one hospital is 'best'.
- Check current disease-specific certification where available
- Confirm access to multidisciplinary tumor-board review
- Ask which records can be assessed before travel
- Use the hospital's official international-patient channel
- Request an individualized treatment and cost estimate before booking
Sources and review
This guide was last source-reviewed on 2026-08-29.